New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

Palatin Technologies To Present At The 27th Annual ROTH Conference

CRANBURY, N.J., March 6, 2015 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that it will be presenting at the 27th Annual ROTH Conference on Wednesday, March 11, 2015, at 10:30 a.m. Pacific Time.  The conference will be held at the Ritz Carlton Laguna Niguel in Dana Point, CA.

Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin’s corporate and development programs.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin’s website at www.palatin.com.

SOURCE Palatin Technologies, Inc.

Related Links

http://www.palatin.com

Scroll to Top